Product Information
SERTRALINE 150 MG CAPSULE is a generic product labeled by Alvogen Inc., priced at $2.5673 per EA under NDC 47781095130. Its NADAC has been published 35 times since Oct 29, 2025.
Strength
150 mg/1
Manufacturer
Alvogen Inc.NDC
47781095130
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA215133On Market Since
9/18/2025
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE 150 MG CAPSULE has been published 35 times since Oct 29, 2025, and over the history we have for it it has declined 50.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5673 per EA |
|---|---|
| All-time high | $5.1702 (Nov 12, 2025) |
| All-time low | $2.5673 (Jun 17, 2026) |
| 52-week high | $5.1702 |
| 52-week low | $2.5673 |
| Median price | $4.8266 |
| Average price | $4.6074 |
| Largest weekly change | -27.8% (Jun 17, 2026) |
| Weeks tracked | 35 |
| Tracking since | Oct 29, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SERTRALINE 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE 150 MG CAPSULE, manufactured by Alvogen Inc., is $2.5673 per EA (NDC 47781095130), effective Jun 24, 2026.
How has the price of SERTRALINE 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for SERTRALINE 150 MG CAPSULE has declined 50.3%. It has been tracked across 35 weekly CMS publications since Oct 29, 2025.
What are the highest and lowest recorded NADAC prices for SERTRALINE 150 MG CAPSULE?
Since Oct 29, 2025, the NADAC for SERTRALINE 150 MG CAPSULE has ranged from a low of $2.5673 (Jun 17, 2026) to a high of $5.1702 (Nov 12, 2025), with a median of $4.8266 per EA.
Are there cheaper alternatives to SERTRALINE 150 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SERTRALINE 150 MG CAPSULE, but none are currently priced below it.
Who manufactures SERTRALINE 150 MG CAPSULE?
SERTRALINE 150 MG CAPSULE (NDC 47781095130) is labeled by Alvogen Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification